13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 39 holding rows worth $989,642,000.
- Accession
- 0001567619-19-017041
- Filer
- CIK 1587114
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 40 entries on the cover page, a total value of $989,642,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $989,642,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 5,276,753 | $103,899,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 2,336,557 | $95,635,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 581,165 | $82,281,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 1,610,250 | $75,843,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,511,785 | $68,302,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 614,128 | $62,874,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 597,711 | $61,564,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,316,407 | $52,233,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,671,408 | $51,105,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,266,804 | $44,928,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 497,899 | $31,617,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 2,392,556 | $31,582,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,486,979 | $28,015,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 3,043,827 | $22,737,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 1,348,423 | $17,529,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 772,096 | $17,125,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 1,300,000 | $14,313,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 277,500 | $12,537,000 | thousands by filing date | call |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,136,043 | $12,042,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,488,205 | $11,787,000 | thousands by filing date | |
| UNITY BIOTECHNOLOGY INC | 91381U101 | COM | 1,044,500 | $9,923,000 | thousands by filing date | |
| CYCLERION THERAPEUTICS INC | 23255M105 | COM | 776,206 | $8,888,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 723,300 | $7,645,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 463,152 | $7,285,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 498,300 | $6,723,000 | thousands by filing date | call |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 2,312,688 | $6,522,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,392,231 | $5,639,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 2,982,208 | $5,547,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 2,265,880 | $5,347,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 223,167 | $4,910,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 827,000 | $4,755,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 316,900 | $4,639,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 583,293 | $4,497,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 1,761,421 | $2,713,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 131,001 | $2,475,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 248,480 | $2,301,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 1,111,110 | $1,389,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 52,120 | $265,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 16,114 | $231,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-017041 | this filing | 2019-08-14 | acceptance time not in the bulk data set |